The association of increased RDV load in CPD, DDR, FA and SCD gene-sets with increased personalized cancer risk in both discovery and validation cohorts have important implications for our understanding of how germline genetic factors govern cancer risk, and can impact the clinical management of cancer patients with one or more germline RDVs, and their families. Here, SCD is linked to cancer.